Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 222,134	$ 243,164
Restricted cash	11,595	10,760
Accounts receivable, net	4,418	5,055
Current contract assets, net	24,015	9,973
Income tax receivable	4,015	3,558
Other current assets	6,391	3,215
Total current assets	272,568	275,725
Property and equipment, net	518	729
Capitalized software development costs, net	4,645	5,386
Operating lease right-of-use assets, net	3,273	3,878
Contract assets	3,087	5,094
Other assets	3,560	5,556
Total assets	287,651	296,368
Current liabilities
Accounts payable	1,038	953
Accrued expenses	8,640	5,166
Current portion of debt	7,500	7,500
Third-party claims administration liability	11,650	10,797
Current portion of excess profit share receipts	17,231	19,346
Other current liabilities	2,700	3,490
Total current liabilities	48,759	47,252
Long-term debt, net of deferred financing costs	126,852	132,217
Operating lease liabilities	2,613	3,273
Excess profit share receipts	30,001	28,210
Other liabilities	6,601	7,329
Total liabilities	214,826	218,281
Commitments and contingencies
Stockholders’ equity
Preferred stock, $0.01 par value; $10,000,000 shares authorized, none issued and outstanding	0	0
Common stock, $0.01 par value; 550,000,000 shares authorized, 128,198,185 shares issued and 118,175,598 shares outstanding as of September 30, 2025 and 128,198,185 shares issued and 119,350,001 shares outstanding as of December 31, 2024	1,282	1,282
Additional paid-in capital	496,827	502,664
Accumulated deficit	(334,677)	(328,759)
Treasury stock at cost, $10,022,587 shares at September 30, 2025 and $8,848,184 shares at December 31, 2024	(90,607)	(97,100)
Total stockholders’ equity	72,825	78,087
Total liabilities and stockholders’ equity	$ 287,651	$ 296,368